Syngene Accelerator Award

Win six months of Integrated Drug Discovery services with a trusted partner

Are you a biotech company pursuing groundbreaking science with limited resources? We’re launching a unique opportunity to help you accelerate your preclinical drug discovery pipeline — with six months of Integrated Drug Discovery support.

Why We Are Offering This

At Syngene, we partner with biotech innovators to push the boundaries of drug discovery. We understand that early-stage science often outpaces funding, especially in the current fiscally constrained environment — and we want to help bridge that gap.

This competition reflects our commitment to supporting the next generation of therapeutic breakthroughs.

What the Award Includes

Our integrated platform combines deep therapeutic expertise with operational excellence and scientific project management to help translate your early insights into actionable candidates. Syngene will provide a dedicated team of up to five FTEs that will support your project for six months at any stage including:

Assay development and in vitro profiling

Hit-to-Lead expansion

Lead optimization

In vivo pharmacology

Who Should Apply?

We welcome applications from early-stage companies across all therapeutic areas and all modalities. Selection will be based on:

  • Scientific innovation and potential impact
  • Quality of preliminary data or biological rationale
  • Alignment on collaboration goals and timelines

Key Dates

Applications Open:
Sept 1st 2025

Application Deadline:
Sept 30th 2025

Finalists Notified:
Oct 14th 2025

Finalists Pitch and Award Event: Oct 21st 2025

How to Apply

Instructions for Application Submission 

Please complete the presentation template with the following details and email the completed presentation to Submissions@syngeneintl.com:

  1. Company Overview
    Provide a non-confidential overview of your company, including your mission, capabilities, and relevant experience.
  2. Lead Program Summary
    Include a 1–2 page summary or pitch deck describing your lead program. This should highlight the therapeutic area, target, and stage of development.
  3. Scientific Rationale
    Present key data supporting the scientific rationale behind your lead program. Include relevant preclinical or clinical findings, if available.
  4. Project Goals
    Clearly outline the goals you aim to accomplish with support from Syngene. Specify the scope, expected outcomes, and how Syngene’s capabilities will be leveraged.

Please ensure all content is formatted and presented using the attached template to maintain consistency and clarity.

Questions?

Please reach out to [Submissions@syngeneintl.com] for more information or clarification about the application process.

Together, we can advance science with purpose — and help turn great ideas into medicines.

© 2025 Syngene International Limited. All rights reserved

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details